Midline Versus Dorsolateral Spinal Cord Stimulation for Post-surgical Neuropathic Pain
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNova Scotia Health Authority
About this trial
The goal of this interventional study is to learn if dorsolateral spinal cord stimulation (DL-SCS) can treat focal post-surgical, medically refractory neuropathic pain. The main question it aims to answer is:
\- How does DL-SCS compare to traditional SCS and no treatment for treating post-surgical neuropathic pain?
Participants will be asked to
* trial combinations of stimulation across blocks of weeks (randomized cross-over) * rate their pain after each stimulation trial
Eligibility criteria
Qualifiers
Diagnosis of neuropathic pain following a surgical procedure
A minimum of 50% of pain should be limited to one body part, defined as one limb or one side of trunk.
Failed conservative therapies (medication, physiotherapy)
Disability more than 6 months
Disqualifiers
Previous implantation with SCS (i.e. revision surgery)
Any underlying condition that would preclude an MRI
Untreated psychiatric conditions or substance use disorder
Existing medical conditions that would preclude from SCS (history of recurrent infections, uncontrolled cancer, etc.)
Trial design
Treatments tested in this trial
- Spinal Cord Stimulator
Treatment groups
40 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov